
    
      Plasma sample of patients with and without lung cancer will be collected and analyzed using
      methylation-sensitive enzyme sequencing method. Diagnostic performance of ctDNA methylation
      sequencing will be compared with that of tumor markers (CEA, Cyfra 21-1, and NSE) combined.
    
  